BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17093904)

  • 1. TGF-beta during human colorectal carcinogenesis: the shift from epithelial to mesenchymal signaling.
    Matsuzaki K; Seki T; Okazaki K
    Inflammopharmacology; 2006 Dec; 14(5-6):198-203. PubMed ID: 17093904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
    Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
    Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta during carcinogenesis: the shift from epithelial to mesenchymal signaling.
    Matsuzaki K; Okazaki K
    J Gastroenterol; 2006 Apr; 41(4):295-303. PubMed ID: 16741607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smad3 phosphoisoform-mediated signaling during sporadic human colorectal carcinogenesis.
    Matsuzaki K
    Histol Histopathol; 2006 Jun; 21(6):645-62. PubMed ID: 16528675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceleration of Smad2 and Smad3 phosphorylation via c-Jun NH(2)-terminal kinase during human colorectal carcinogenesis.
    Yamagata H; Matsuzaki K; Mori S; Yoshida K; Tahashi Y; Furukawa F; Sekimoto G; Watanabe T; Uemura Y; Sakaida N; Yoshioka K; Kamiyama Y; Seki T; Okazaki K
    Cancer Res; 2005 Jan; 65(1):157-65. PubMed ID: 15665291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
    Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
    Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
    Matsuzaki K; Murata M; Yoshida K; Sekimoto G; Uemura Y; Sakaida N; Kaibori M; Kamiyama Y; Nishizawa M; Fujisawa J; Okazaki K; Seki T
    Hepatology; 2007 Jul; 46(1):48-57. PubMed ID: 17596875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells.
    Li Q; Liu G; Yuan H; Wang J; Guo Y; Chen T; Zhai R; Shao D; Ni W; Tai G
    Oncotarget; 2015 Feb; 6(6):4253-65. PubMed ID: 25714018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic Smad3 signaling induced by chronic inflammation is an early event in ulcerative colitis-associated carcinogenesis.
    Kawamata S; Matsuzaki K; Murata M; Seki T; Matsuoka K; Iwao Y; Hibi T; Okazaki K
    Inflamm Bowel Dis; 2011 Mar; 17(3):683-95. PubMed ID: 20602465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic alterations of the TGF-beta signaling pathway in colorectal cancer cell lines: a novel mutation in Smad3 associated with the inactivation of TGF-beta-induced transcriptional activation.
    Ku JL; Park SH; Yoon KA; Shin YK; Kim KH; Choi JS; Kang HC; Kim IJ; Han IO; Park JG
    Cancer Lett; 2007 Mar; 247(2):283-92. PubMed ID: 16828225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant Smad3 phosphoisoforms in cyst-lining epithelial cells in the
    Hama T; Nakanishi K; Sato M; Mukaiyama H; Togawa H; Shima Y; Miyajima M; Nozu K; Nagao S; Takahashi H; Sako M; Iijima K; Yoshikawa N; Suzuki H
    Am J Physiol Renal Physiol; 2017 Dec; 313(6):F1223-F1231. PubMed ID: 28877884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Smad3 phosphoisoform-mediated signaling in the development of colonic cancer in IL-10-deficient mice.
    Hachimine D; Uchida K; Asada M; Nishio A; Kawamata S; Sekimoto G; Murata M; Yamagata H; Yoshida K; Mori S; Tahashi Y; Matsuzaki K; Okazaki K
    Int J Oncol; 2008 Jun; 32(6):1221-6. PubMed ID: 18497983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
    Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
    Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis.
    Roberts AB; Tian F; Byfield SD; Stuelten C; Ooshima A; Saika S; Flanders KC
    Cytokine Growth Factor Rev; 2006; 17(1-2):19-27. PubMed ID: 16290023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad4-independent TGF-beta signaling in tumor cell migration.
    Giehl K; Imamichi Y; Menke A
    Cells Tissues Organs; 2007; 185(1-3):123-30. PubMed ID: 17587818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta signaling: a tale of two responses.
    Rahimi RA; Leof EB
    J Cell Biochem; 2007 Oct; 102(3):593-608. PubMed ID: 17729308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad phospho-isoforms direct context-dependent TGF-β signaling.
    Matsuzaki K
    Cytokine Growth Factor Rev; 2013 Aug; 24(4):385-99. PubMed ID: 23871609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.
    Gordon KJ; Dong M; Chislock EM; Fields TA; Blobe GC
    Carcinogenesis; 2008 Feb; 29(2):252-62. PubMed ID: 17999987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
    Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
    Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of transforming growth factor beta on human neuroendocrine tumor BON cell proliferation and differentiation is mediated through somatostatin signaling.
    Leu FP; Nandi M; Niu C
    Mol Cancer Res; 2008 Jun; 6(6):1029-42. PubMed ID: 18567806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.